EURO SHOCK: Testing the value of a novel strategic approach and its cost efficacy to improve the poor outcomes i...
AZIENDA SOCIO SANITARIA TERRITORIALE PAPA GIOVANNI XXIII
participó en un
H2020:
H2020-SC1-2016-2017
Heart attacks are common and can leave survivors suffering cardiogenic shock (CGS), with its extremely high risk of early death (42% versus...
2017-12-05 - 2022-12-31 | Financiado
2017-12-05 - 2022-12-31 | Financiado
CureCN: Adeno Associated Virus Vector Mediated Liver Gene Therapy for Crigler Najjar Syndrome
AZIENDA SOCIO SANITARIA TERRITORIALE PAPA GIOVANNI XXIII
participó en un
H2020:
H2020-SC1-2016-2017
Crigler-Najjar syndrome (CN) is a rare recessive disorder caused by mutations in the uridine diphosphate glucuronosyltransferase 1A1(UGT1A1)...
2017-12-05 - 2023-12-31 | Financiado
2017-12-05 - 2023-12-31 | Financiado
* No se disponen de datos de la empresa actual.